Did Novo-Nordisk A/S fall, leaving Eli Lilly and Co to dominate the weight loss medication market?
Novo-Nordisk A/S faced a "Waterloo," with new drug effects falling short of expectations, causing a dramatic drop in stock prices. The landscape of the weight loss drug market is quietly changing; will Eli Lilly and Co become a sole oligopoly?
Tesla Cybertruck Units Reportedly Found With Cell Dent Issues: EV Giant Starts Replacing Battery Packs
Options Market Statistics: Tesla's Rollercoaster Week Ends with Friday Sell-Off; Options Pop
Tesla Model Y Could Lose Bestselling Title In Europe To This Non-EV Car
Weekly Buzz: It was a rough week just before the Winter Solstice
Jury Finds Qualcomm Did Not Breach Nuvia's License Agreement With Arm
Pfizer Gets FDA Accelerated Approval for Braftovi
Which Magnificent 7 Stock Will Do Best In Santa Claus Rally? Tesla Edged Out As 28% Select...
50 Analysts Assess Amazon.com: What You Need To Know
Catalyst Watch: Labor Pains for Amazon & Starbucks, Nasdaq Call-up for MicroStrategy and Pony AI Ratings
OpenAI Reveals New Frontier Model O3; Says It Crushes Prior AI Benchmarks
Google Says Starting Jan 15, Advertisers Offering Cryptocurrency Exchanges Targeting UK May Advertise When They Meet Some Requirements, Certified By Co
Potential TikTok Bidder Frank McCourt Says He Is Seeking A New CEO For The Company; TikTok Could Earn Revenue From Ecommerce And Data Licensing, Reduce Reliance On Ads
UBS Says 'Underweight the Names With High China Exposure'
Morgan Stanley Maintains Overweight on Broadcom, Raises Price Target to $265
Broadcom Analyst Ratings
J.P. Morgan's Top Technology Stocks for 2025
10 Information Technology Stocks Whale Activity In Today's Session
EXCLUSIVE: Weight-Loss Market Experts Scoop Up Novo Nordisk Stock After Worst Drop Since 2002 Following Drug Trial Miss
Unpacking the Latest Options Trading Trends in NVIDIA